The united kingdom generic injectables market is witnessing remarkable growth, with a projected compound annual growth rate (CAGR) of 6.0%. The market is expected to expand from USD 7.9 million in 2025 to USD 14.2 million by 2035, driven by increasing demand for cost-effective medicines and regulatory support for generic drug adoption. A key contributor …